Galectin Therapeutics (GALT) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.81% |
| Dec 31, 2025 | -55.66% |
| Sep 30, 2025 | -73.34% |
| Jun 30, 2025 | -91.44% |
| Mar 31, 2025 | -143.28% |
| Dec 31, 2024 | -392.35% |
| Sep 30, 2024 | -143.95% |
| Jun 30, 2024 | -95.30% |
| Mar 31, 2024 | -67.36% |
| Dec 31, 2023 | -68.19% |
| Sep 30, 2023 | -55.55% |
| Jun 30, 2023 | -51.80% |
| Mar 31, 2023 | -45.52% |
| Dec 31, 2022 | -40.49% |
| Sep 30, 2022 | -35.79% |
| Jun 30, 2022 | -32.75% |
| Mar 31, 2022 | -52.50% |
| Dec 31, 2021 | -44.33% |
| Sep 30, 2021 | 1.28% |
| Jun 30, 2021 | 24.11% |
| Mar 31, 2021 | 161.34% |
| Dec 31, 2020 | 254.09% |
| Sep 30, 2020 | 215.78% |
| Jun 30, 2020 | 105.04% |
| Mar 31, 2020 | 73.09% |
| Dec 31, 2019 | 62.14% |
| Sep 30, 2019 | 66.73% |
| Jun 30, 2019 | 88.19% |
| Mar 31, 2019 | -25.68% |
| Dec 31, 2018 | -34.05% |
| Sep 30, 2018 | -17.36% |
| Jun 30, 2018 | -23.35% |
| Mar 31, 2018 | -65.15% |
| Dec 31, 2017 | -26.52% |
| Sep 30, 2017 | -65.58% |
| Jun 30, 2017 | -45.81% |
| Mar 31, 2017 | -34.59% |
| Dec 31, 2016 | 90.83% |
| Sep 30, 2016 | 99.39% |
| Jun 30, 2016 | 64.16% |
| Mar 31, 2016 | 141.24% |
| Dec 31, 2015 | 149.25% |
| Sep 30, 2015 | 61.32% |
| Jun 30, 2015 | 53.88% |
| Mar 31, 2015 | 47.38% |
| Dec 31, 2014 | 128.78% |
| Sep 30, 2014 | 204.42% |
| Jun 30, 2014 | 204.07% |
| Dec 31, 2013 | 42.18% |